FOLH1 and prostate cancer: Surprisingly, microarray analysis revealed knockdown of SSX2 also resulted in a knockdown of the androgen receptor (AR) and prostate specific membrane antigen (PSMA), both of which are intrinsically tied to prostate cancer disease progression [39, 40].